Last reviewed · How we verify
NCT06167434
Future Cardia™ Insertable Cardiac Monitor in Subjects With Paroxysmal Atrial Fibrillation (First-in-Human Study)
NA trial testing Future Cardia™ Insertable Cardiac Monitoring (ICM) System in Arrhythmias, Cardiac in 30 participants. Participants enrolled and being followed up; not accepting new ones.
1 June 2026
Quick facts
| Lead sponsor | Future Cardia, Inc |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 30 |
| Start date | 1 December 2023 |
| Primary completion | 1 June 2026 |
| Estimated completion | 1 December 2026 |
| Sites | 1 location across Croatia |
Drugs / interventions tested
- Future Cardia™ Insertable Cardiac Monitoring (ICM) System
Conditions studied
- Arrhythmias, Cardiac — all drugs for Arrhythmias, Cardiac →
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
- Bradycardia — all drugs for Bradycardia →
- Ventricular Tachycardia — all drugs for Ventricular Tachycardia →
Sponsor
Future Cardia, Inc
Who can join
Adults 18 to 75, any sex, with Arrhythmias, Cardiac or Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a first-in-human, prospective, multi-center, pre-market single-arm clinical trial to evaluate the Future Cardia™ ICM.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Invasive and Non-Invasive Remote Patient Monitoring Devices for Heart Failure: A Comparative Review of Technical Maturity and Clinical Readiness.
Luque I, Gadea M, Comas A, Becerra-Fajardo L, et al · · 2025 · cited 1× · PMID 41157505 · DOI 10.3390/s25206453
Verify or expand the search:
- PubMed search for NCT06167434
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Arrhythmias, Cardiac
Currently open trials in the same condition.
- NCT07276139 — PACEVALUE: Development of a Risk Score to Predict Pacing-Induced Cardiomyopathy in Patients Undergoing Pacemaker or ICD · active not recruiting
- NCT06954610 — Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation · recruiting
- NCT06360939 — Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease · NA · recruiting
- NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
- NCT06358391 — To Compare and Evaluate the Efficacy and Safety Between TS-RF System and BRK Transseptal Needles Used for Transseptal Pu · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06167434 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Future Cardia, Inc
- Last refreshed: 8 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06167434.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing